28. May 2018

Anaqua published on Huffington Post and “Wallstreet Online”

No softening of European patent law, because this would weaken the medical location Germany. This is the tenor of an article on wallstreet online, in which our client Anaqua is quoted extensively. “However, with barriers to investment and discussion already underway, there is always a risk of relocating to other regions, if not the complete reduction of billion dollar research in the pharmaceutical sector,” says Michael Klein, head of Anaqua Germany, a mid-sized company with 300 employees headquartered in Boston, with offices in France, Germany and China, develops and distributes innovative, web-based software for managing and analyzing patents and related rights.

The background to this is the European Commission’s attempt to examine whether certain aspects of patent and so-called SPC protection need to be realigned. This would affect above all the pharmaceutical sector.

Read the full article HERE.

This article was also featured in a modified version in Huffington Post, please see HERE.